Preferences for Weight Loss Treatment Amongst Treatment-Seeking Patients with Severe Obesity: A Discrete Choice Experiment.


Journal

Applied health economics and health policy
ISSN: 1179-1896
Titre abrégé: Appl Health Econ Health Policy
Pays: New Zealand
ID NLM: 101150314

Informations de publication

Date de publication:
10 2020
Historique:
pubmed: 25 1 2020
medline: 19 8 2021
entrez: 25 1 2020
Statut: ppublish

Résumé

Treatment options for weight loss vary considerably with regard to risks and benefits, but the relative importance of treatment characteristics in patient decision-making is largely unknown, particularly amongst patients with severe obesity. Developing such services requires insight into the preferences of recipients for service attributes. The objective of this study was to quantify, using a discrete choice experiment, the preferences of treatment-seeking patients with severe obesity within the Irish population regarding different attributes of various obesity treatments. Within a cohort of patients with severe obesity attending a hospital-based weight management programme, patients' attitudes to and perceptions of three distinct treatment modalities were compared to those regarding not having treatment. The treatments included a structured lifestyle modification programme, lifestyle modification alongside weight loss medication, and bariatric surgery. On average, patients with severe and complicated obesity who were attending a weight management programme were more enthusiastic about participating in a programme to help improve their diet and physical activity than they were about having surgery if the methods of treatment had equivalent results and costs. The findings provide insights into preferences that might assist the development of more appropriate treatments for severe obesity.

Sections du résumé

BACKGROUND
Treatment options for weight loss vary considerably with regard to risks and benefits, but the relative importance of treatment characteristics in patient decision-making is largely unknown, particularly amongst patients with severe obesity. Developing such services requires insight into the preferences of recipients for service attributes.
OBJECTIVE
The objective of this study was to quantify, using a discrete choice experiment, the preferences of treatment-seeking patients with severe obesity within the Irish population regarding different attributes of various obesity treatments.
METHODS
Within a cohort of patients with severe obesity attending a hospital-based weight management programme, patients' attitudes to and perceptions of three distinct treatment modalities were compared to those regarding not having treatment. The treatments included a structured lifestyle modification programme, lifestyle modification alongside weight loss medication, and bariatric surgery.
RESULTS
On average, patients with severe and complicated obesity who were attending a weight management programme were more enthusiastic about participating in a programme to help improve their diet and physical activity than they were about having surgery if the methods of treatment had equivalent results and costs.
CONCLUSION
The findings provide insights into preferences that might assist the development of more appropriate treatments for severe obesity.

Identifiants

pubmed: 31974934
doi: 10.1007/s40258-020-00554-z
pii: 10.1007/s40258-020-00554-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

689-698

Auteurs

Michelle Queally (M)

Discipline of Economics, JE Cairnes School of Business and Economics, NUI Galway, Galway, Ireland.

Edel Doherty (E)

Discipline of Economics, JE Cairnes School of Business and Economics, NUI Galway, Galway, Ireland.

Francis Finucane (F)

Bariatric Medicine Service, Galway Diabetes Research Centre and HRB CRF, NUI Galway, Galway, Ireland.

Ciaran O'Neill (C)

Centre for Public Health, Queens University Belfast, Belfast, UK. ciaran.oneill@qub.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH